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Abstract: Zinc chloride is used as a source of zinc in various pharmaceutical/nutraceutical formulations. The aim of the 
current study was to investigate the impact of The Trivedi Effect® - Consciousness Energy Healing Treatment (Biofield Energy 
Treatment) on physical, structural, thermal, and behavioral properties of zinc chloride using PXRD, PSD, FT-IR, UV-vis, and 
DSC analysis. Zinc chloride was divided into two parts – one part was control, while another part was treated with The Trivedi 
Effect® - Consciousness Energy Healing Treatment remotely by twenty renowned Biofield Energy Healers and defined as the 
Biofield Energy Treated sample. A significant alteration of the crystallite size and relative intensities of the PXRD peaks was 
observed in The Trivedi Effect® treated sample compared with the control sample. The average crystallite size of the treated 
sample was significantly increased by 16.43% compared with the control sample. The particles size values of the treated 
sample at d10 was decreased by 2.42%, whereas at d50, and d90 it was increased slightly by 0.43%, and 0.57%, respectively 
compared to the control sample. Therefore, the surface area of the treated sample was increased by 1.63% compared with the 
control sample. The FT-IR spectroscopic analysis revealed that Zn-Cl stretching in the control sample was found at 511 cm-1, 
whereas it was shifted downward to 508 cm-1 in the treated sample. The UV-vis analysis exhibited that wavelength of the 
maximum absorbance (λmax) of the control and treated samples were at 196.4 nm and 196.2 nm, respectively. The DSC 
analysis exhibited that the melting temperature was not altered significantly, while the decomposition temperature was 
increased by 0.45% in the treated sample compared to the control sample. The latent heat of fusion of the treated sample 
(402.09 J/g) was significantly increased by 29.78% compared with the control sample (309.83 J/g). Similarly, the enthalpy of 
decomposition of the treated sample (243.13 J/g) was significantly decreased by 61.18% compared with the control sample 
(626.37 J/g). This indicated that the thermal stability of the treated sample might be improved compared to the control sample. 
The current study anticipated that the Consciousness Energy Healing Treatment might lead to produce a new polymorphic 
form of zinc chloride, which would be more soluble, bioavailable, and thermally more stable compared with the control 
sample. Hence, the treated zinc chloride would be very useful to design better nutraceutical/pharmaceutical formulations that 
might offer better therapeutic response against immunological disorders, inflammatory diseases, stress, aging, cancer, etc. 
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1. Introduction 
Zinc is an essential element in the human body, which 
regulates a broad spectrum of physiological functions. It 
plays an important role in the human body, which are 
involved in the nucleic acid, protein metabolism and for the 
production of energy. Zinc also maintains the structural 
integrity of the biological membranes resulting in their 
protection against oxidative injury [1-2]. It possesses various 
pharmacological activities include retino-protective, fertility 
enhancing, and putative antiviral activities [3]. Zinc is also 
used in the treatment of Wilson’s disease [4]. It has also 
immunomodulatory and antioxidant activities [1]. Zinc also 
prevent the development of several deficiency symptoms 
include hypogeusia, parakeratosis, anorexia, geophagia, 
dysosmia, growth retardation, hypogonadism, etc. [5-7]. 
Recently, it has been reported that zinc had increased the 
phagocytic index, and leukocyte count which potentiate the 
immunomodulatory effect along with Glycyrrhiza glabra [8]. 
Zinc chloride (ZnCl2) is a hygroscopic inorganic salt and 
highly soluble in water [9]. It is used in pharmaceutical 
industry as drug and diagnostic agent due to its powerful 
astringent and mild antiseptic properties [10]. It is also used 
in deodorant and mouth-wash preparations. Zinc chloride is 
used as dentin desensitizer i.e. reduces the sensitivity of the 
teeth to heat and cold, along with protein precipitation and 
insulin preparation [10, 11]. The literature reported that zinc 
chloride has also been used in the treatment of cancer as a 
destructive agent [12] and in the pluripotency maintenance of 
mouse embryonic stem cell through the regulation of STAT3 
signaling pathway [13]. Zinc chloride can be used for the 
palliative treatment of canine and malignant skin wounds 
[14]. It has the reverse effect on the locomotor behavior of 
rats [15]. Therefore, zinc chloride was considered as one of 
the components in the novel proprietary herbomineral 
formulation for the source of zinc and can be used for the 
prevention and treatment of various human disorders.  
An élan vital or vital force which contributes the ‘life’ is 
preserved by every living organisms and known as prana by 
the Hindus, qi or chi by the Chinese, and ki by the Japanese. 
This is believed to co-relate with the soul, spirit, and mind. 
This hypothetical vital force is considered as the Biofield 
Energy. The Biofield Energy is infinite, paradimensional and 
dynamic electromagnetic field surrounding the human body. 
It can freely flow between the human and environment that 
leads to the continuous movement or matter of energy [16, 
17]. Thus, a human has the ability to harness energy from the 
earth, the “universal energy field” and transmit it to any 
living or nonliving object(s) around the globe. The objects 
always receive the energy and respond in a useful way. This 
process is known as Biofield Energy Healing Treatment [18, 
19]. Biofield (Putative Energy Fields) based Energy 
Therapies are used worldwide to promote health and healing. 
The National Center of Complementary and Integrative 
Health (NCCIH) has been recognized and accepted Biofield 
Energy Healing as a Complementary and Alternative 
Medicine (CAM) health care approach in addition to other 
therapies, medicines and practices such as natural products, 
deep breathing, yoga, Qi Gong, Tai Chi, 
chiropractic/osteopathic manipulation, meditation, special 
diets, massage, homeopathy, progressive relaxation, guided 
imagery, acupuncture, acupressure, relaxation techniques, 
healing touch, hypnotherapy, movement therapy, rolfing 
structural integration, pilates, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, aromatherapy, essential oils, cranial sacral 
therapy Reiki, and applied prayer (as is common in all 
religions, like Hinduism, Christianity, Buddhism and 
Judaism) [20]. Biofield Energy Treatment (The Trivedi 
Effect®) has been reported in numerous peer-reviewed 
science journals with significant outcomes in many scientific 
fields such as cancer research [21], altered antimicrobial 
sensitivity of pathogenic microbes in microbiology [22-24], 
biotechnology [25, 26], genetics [27, 28], changing the 
atomic structure in relation to various metals, ceramics, 
polymers and chemicals [29, 30], altered physical and 
chemical properties of pharmaceuticals [31, 32], 
nutraceuticals [33, 34], organic compounds [35-37], and 
improved overall growth and yield of plants in agricultural 
science [38, 39]. The physicochemical properties such as 
particle size, crystallite size, crystalline structure, surface 
area, and thermal properties of a drug have a vital role in 
bioavailability as well as the stability of the drug during 
processing, formulation, packaging, and storage [40, 41]. The 
particle size, surface area, crystalline nature, chemical and 
thermal behavior of an atom/ion might be altered by the 
Biofield Energy Healing Treatment (The Trivedi Effect®) 
through the possible mediation of neutrinos [42]. By 
considering all these aspects, powder X-ray diffraction 
(PXRD), particle size distribution analysis (PSD), Fourier 
transform infrared (FT-IR) spectrometry, ultraviolet-visible 
(UV-vis) spectroscopy, and differential scanning calorimetry 
(DSC) analytical techniques were conducted in this study for 
the characterization of physical, structural, and thermal 
properties of the Biofield Energy Treated and untreated zinc 
chloride. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Zinc chloride was procured from Tokyo Chemical Industry 
Co., Ltd. (TCI), Japan. All other chemicals used in the 
experiment were of analytical grade available in India. 
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2.2. The Trivedi Effect
®
 Energy of Consciousness Healing 
Treatment Strategies 
Zinc chloride was one of the components of the new 
proprietary herbomineral formulation, developed by our 
research team and it was used per se as the test compound for 
the current study. The test compound was divided into two 
parts, one part of the test compound did not receive any sort 
of treatment and was defined as the untreated or control zinc 
chloride sample. The second part of the test compound was 
treated with The Trivedi Effect® - Energy of Consciousness 
Healing Treatment (Biofield Energy Treatment) by a group 
of twenty renowned Biofield Energy Healers remotely and 
was denoted as Biofield Energy Treated or The Trivedi 
Effect® sample. Fifteen Biofield Energy Healers were 
remotely located in the U.S.A., two in Canada, one in the 
UK, one in Australia, and one in Germany, while the test 
compound was located in the research laboratory of GVK 
Biosciences Pvt. Ltd., Hyderabad, India. This Biofield 
Energy Treatment was provided for 5 minutes through 
Healer’s Unique Energy Transmission process remotely to 
the test compound under the laboratory conditions. None of 
the Biofield Energy Healers in this study visited the 
laboratory in person, nor had any contact with the 
compounds. Similarly, the control compound was subjected 
to “sham” healers for 5 minutes, under the same laboratory 
conditions. The sham healer did not have any knowledge 
about the Biofield Energy Treatment. After that, the Biofield 
Energy Treated and untreated samples were kept in similar 
sealed conditions and characterized thoroughly by PXRD, 
PSD, FT-IR, UV-visible spectroscopy, and DSC analysis.  
2.3. Characterization 
2.3.1. Powder X-Ray Diffraction (PXRD) Analysis 
The PXRD analysis was accomplished on PANalytical 
X’Pert Pro powder X-ray diffractometer system. The X-ray 
of wavelength 1.54056 Å was used. The data was collected in 
the form of a chart of the Bragg angle (2θ) vs. intensity, and a 
detailed table containing information on peak intensity 
counts, d value (Å), relative intensity (%), full width half 
maximum (FWHM) (θ°). From the PXRD results, the 
crystallite size (G) was calculated using X’Pert data collector 
and X’Pert high score plus processing software. The 
crystallite size (G) was calculated from the Scherrer equation 
[43, 44]. The method was based on the width of the 
diffraction patterns obtained in the X-ray reflected the 
crystalline region. The crystallite size (G) was calculated by 
using the following formula (1): 
G = kλ/(bCosθ)                                 (1) 
Where, k is the equipment constant (0.5), λ is the X-ray 
wavelength (0.154 nm); b in radians is the full-width at half 
of the peaks and θ the corresponding Bragg angle. 
Percent change in crystallite size (G) was calculated using 
following equation (2): 
%	change	in	crystallite	size	 =
		
	
× 100  (2) 
Where, GControl and GTreated are the crystallite size of the 
control and Biofield Energy Treated samples, respectively. 
A total of ~500 mg of the control and Biofield Energy 
Treated samples individually were used for the analysis and 
prepared by back loading technique using the sample 
preparation kit. The sample was spread on the holder ring in 
sufficient quantity to fill the ring cavity. It was then pressed 
down using powder press block and scrap the powder that 
was in surplus using a glass slide to get densely packed 
specimen. Consequently, the bottom plate was placed onto 
the holder ring and clamp in position. The sample holder was 
then removed from the sample preparation table by turning it 
upside down. A smooth surface of the sample was obtained 
to ensure optimum results. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution 
were analyzed using Malvern Mastersizer 2000, UK with a 
detection range between 0.01 µm to 3000 µm. The sample 
unit was filled with the dispersant medium (sunflower oil) 
and operated the stirrer at 2500 rpm. Alignment of the optics 
was done and the background measurement was taken. After 
the background measurement, the sample was added into the 
sample unit with constant monitoring the obscuration and 
stopped the addition of sample when the obscuration reached 
in between 15% to 20%. When the obscuration was stable, 
the measurement was taken twice and the average of two 
measurements was taken. The average histogram of the two 
measurements was recorded. The data was presented in the 
table format which includes particle size (µm). Also, the 
values at below 10% level (d10), 50% level (d50), and 90% 
level (d90) were calculated from the histogram and the 
calculations such as surface area (m2/g) were done by using 
software Mastersizer 2000. 
Percent change in particle size (d) for at below 10% level 
(d10), 50% level (d50), and 90% level (d90) was calculated 
using following equation (3): 
%	change	in	particle	size =
##
#
× 100   (3) 
Where, dControl and dTreated are the particle size (µm) for at 
below 10% level (d10), 50% level (d50), and 90% level (d90) of 
the control and Biofield Energy Treated samples, 
respectively. 
Percent change in surface area (S) was calculated using 
following equation (4): 
%	change	in	surface	area =
&	&	
&	
× 100   (4) 
Where, SControl and STreated are the surface area of the 
control and Biofield Energy Treated samples, respectively. 
2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR spectroscopy of zinc chloride was performed on 
Spectrum two (Perkin Elmer, USA) Fourier transform 
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infrared spectrometer with the frequency array of 400-4000 
cm-1 by using pressed KBr disk technique. 
2.3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-Vis spectral analysis was carried out using 
Shimadzu UV-2450 with UV Probe, Japan. The spectrum 
was recorded using 1 cm quartz cell that has a slit width of 
1.0 nm. The wavelength range chosen for recording the 
spectra was 190-800 nm. The absorbance spectra (in the 
range of 0.2 to 0.9) and wavelength of maximum absorbance 
(λmax) were recorded. 
2.3.5. Differential Scanning Calorimetry (DSC)
 
 
The analysis was performed using the DSC Q20 (TA 
Instruments, USA) differential scanning calorimeter. A total 
of ~5 mg sample was weighed and sealed in aluminum pans 
and equilibrated at 25°C and heated up to 450ºC at the 
heating rate of 10ºC/min under nitrogen gas as purge 
atmosphere with a flow rate of 50 mL/min. The value for 
onset, endset, peak temperature, peak height (mJ or mW), 
peak area, and change in heat (J/g) for each peak were 
recorded. 
Percent change in the melting/decomposition temperature 
(T) was calculated using following equation (5): 
%	change	in	melting/decomposition	temperature =
++
+
× 100                        (5) 
Where, TControl and TTreated are the decomposition 
temperature of the control and Biofield Energy Treated 
samples, respectively. 
Percent change in the enthalpy of melting/decomposition 
(∆H) was calculated using following equation (6): 
%	change	in	enthalpy	of	melting/decomposition =
∆-.-
.-
× 100                                       (6) 
Where, ∆HControl and ∆HTreated are the enthalpy of 
decomposition of the control and Biofield Energy Treated 
samples, respectively. 
3. Results and Discussion 
3.1. Powder X-ray Diffraction (PXRD) Analysis 
The PXRD diffractograms of the control and Biofield 
Energy Treated zinc chloride are presented in Figure 1. Both 
the samples displayed very sharp and intense peaks in their 
respective diffractogram indicating the crystalline nature of 
zinc chloride. PXRD data such as Bragg angle (2θ), full 
width half maximum (FWHM) (θ°), relative intensity (%), 
and crystallite size (G) for the control and Biofield Energy 
Treated zinc chloride are presented in Table 1. The crystallite 
size was calculated with the help of Scherrer equation [43, 
44]. The crystallite size of the control and Biofield Energy 
Treated samples were found to be similar at 2θ equal to 
nearly 29.3°, 49.2°, and 74.6° (Table 1, entry 3, 7, and 12). 
The crystallite size of the Biofield Energy Treated zinc 
chloride at 2θ equal to nearly 25.4°, 34.9°, 38.2°, 52.3°, 
56.2°, 58.4°, and 61.7° (Table 1, entry 2, 4, 5, and 8-11) was 
significantly increased in the range of 25.04% to 166.82% 
compared with the control sample. Consequently, at 2θ equal 
to 15.6°, 48.6°, and 91.9° (Table 1, entry 1, 6, and 13), the 
crystallite size of the Biofield Energy Treated zinc chloride 
was significantly decreased by 16.73%, 33.35%, and 19.95%, 
respectively compared with the control sample. However, the 
average crystallite size of the Biofield Energy Treated sample 
was significantly increased by 16.43% (Table 1, entry 14) 
compared to the control sample. The PXRD diffractograms 
of both the control and Biofield Energy Treated zinc chloride 
displayed greater intensity at Bragg’s angle (2θ) equal to 
48.6° (Table 1, entry 6). Beside this, the relative intensities of 
the PXRD peaks (Table 1) in the Biofield Energy Treated 
sample were significantly altered compared with the control 
sample. 
Table 1. PXRD data of the control and Biofield Energy Treated zinc chloride. 
Entry 
No. 
Bragg angle (°2θ) Relative Intensity (%) FWHM (°2θ) Crystallite size (G, nm) 
Control Treated  Control Treated  Control Treated  Control Treated  % change* 
1 15.56 15.60 39.59 41.02 0.0836 0.1004 53.14 44.25 -16.73 
2 25.37 25.43 30.40 31.09 0.1673 0.1338 26.97 33.73 25.05 
3 29.29 29.21 29.26 41.66 0.0502 0.0502 90.64 90.63 -0.02 
4 34.90 34.88 91.00 38.44 0.0816 0.0502 56.56 91.93 62.54 
5 38.22 38.21 15.20 20.55 0.2342 0.1338 19.90 34.83 75.03 
6 48.55 48.60 100.00 100.00 0.0669 0.1004 72.21 48.13 -33.35 
7 49.12 49.19 71.85 72.97 0.0612 0.0612 79.12 79.14 0.03 
8 52.18 52.27 12.22 13.29 0.1632 0.1224 30.05 40.08 33.38 
9 56.09 56.16 21.75 46.38 0.1020 0.0816 48.93 61.18 25.04 
10 58.24 58.36 12.93 41.25 0.1632 0.0612 30.90 82.44 166.82 
11 61.70 61.54 19.58 19.69 0.1020 0.0612 50.31 83.78 66.53 
12 74.54 74.64 12.18 16.35 0.0816 0.0816 67.87 67.92 0.07 
13 91.88 91.95 18.72 25.55 0.0816 0.1020 77.74 62.23 -19.95 
14 Average crystallite size 54.18 63.10 16.43 
FWHM: Full width half maximum, *denotes the percentage change in the crystallite size of the Biofield Energy Treated sample with respect to the control 
sample. 
 International Journal of Pharmacy and Chemistry 2017; 3(2): 19-28 23 
 
 
Figure 1. PXRD diffractograms of the control and Biofield Energy Treated zinc chloride. 
The literature reported that the changes in the XRD 
patterns, such as crystallite size and relative intensities, 
indicated the modification of the morphology of the crystal 
as well as the proof of polymorphic transition [45-47]. As the 
crystal morphology of the Biofield Energy Treated sample 
was altered compared with the control sample, the treated 
sample might be a new polymorphic form of zinc chloride. 
The crystal pattern, size and even polymorphic form of a 
pharmaceutical play important roles in drug solubility, 
dissolution, and bioavailability. It has been reported in the 
literature that the alteration in crystal morphology has the 
significant impact on the in vitro rate of dissolution, which is 
related with the bioavailability of orally administered 
pharmaceutical/nutraceutical [41]. Thus, it can be concluded 
that the Biofield Energy Healing Treatment might be a very 
useful method for improving the bioavailability of zinc 
chloride. 
3.2. Particle Size Distribution (PSD) Analysis 
The particle size values and the surface area of the control 
and Biofield Energy Treated zinc chloride were investigated 
and the results are presented in Table 2. It was evident that 
the Biofield Energy Treatment has the ability to reduce the 
particle size of zinc chloride with respect to the control 
sample. The size of the particles in the Biofield Energy 
Treated sample at d10 was decreased by 2.42%, while at d50, 
and d90 it was increased slightly by 0.43%, and 0.57%, 
respectively compared to the control sample. 
Table 2. Particle size data (d10, d50, and d90) and surface area of the control 
and Biofield Energy Treated zinc chloride. 
Parameter 
d10 
(µm) 
d50 
(µm) 
d90 
(µm) 
Surface 
area (m
2/g) 
Control 0.992 2.573 5.975 3.07 
Biofield Energy Treated 0.968 2.584 6.009 3.12 
Percent change (%)* -2.42 0.43 0.57 1.63 
*denotes the percentage change in the particle size data (d10, d5, and d90) and 
surface area of the Biofield Energy Treated sample with respect to the 
control sample. 
The particle size and surface area have the direct effect on 
the dissolution of a compound in a solvent, because the 
surface energy influenced by the surface area and chemical 
affinity is the driving factor for dissolution efficiency [48, 
49]. The surface area for both the control and Biofield 
Energy Treated zinc chloride samples were analyzed and the 
results are presented in Table 2. The surface area of the 
Biofield Energy Treated sample (3.12 m2/g) was increased by 
1.63% compared with the control sample (3.07 m2/g).  
Poorly crystallized compounds possess more surface area 
and higher exchange capacities than well-crystallized 
compounds [50]. In addition, the variation of the crystal 
morphology in the Biofield Energy Treated sample, which 
was well-supported from PXRD data, may cause to alter the 
surface area of the Biofield Energy Treated zinc chloride 
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compared with the control sample. It has been well 
established that the particle size, shape and surface area of 
pharmaceutical compounds have an important impact on 
solubility, dissolution and in vivo bioavailability, as well as 
supports the designing of new drug delivery systems [51, 52]. 
Reducing the particle size and higher surface area would 
enhance the solubility of the solid particles, and consequently 
increase the dissolution rate and bioavailability [53]. Thus, it 
is assumed that the Biofield Energy Treated zinc chloride 
might be more soluble, absorbed at a faster rate and may 
possibly have more bioavailability than the untreated zinc 
chloride. 
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra of the control and Biofield Energy 
Treated samples of zinc chloride are presented in Figure 2. 
The characteristic peaks were observed at 3908, 3589, 3518, 
1930, 1607, 980, and 511 cm-1 in the control FT-IR spectrum 
(Figure 2). On the other hand, the FT-IR spectrum of the 
Biofield Energy Treated zinc chloride showed the notable 
absorption bands at 3902, 3589, 3519, 1931, 1607, 988, and 
508 cm-1 (Figure 2). The strong and broad absorption band 
centered near 3589 cm-1 and the H-O-H bending motion at 
1607 cm-1 that were due to the presence of the lattice water 
was found in the FT-IR spectrum of both the control and 
Biofield Energy Treated samples (Figure 2). Literature 
suggested that the metal-halide stretching absorption band for 
inorganic materials generally found in the 750-100 cm-1 
region [54]. In control spectrum, metal-halogen (Zn-Cl) 
stretching was found at 511 cm-1, whereas it was shifted 
downward in the Biofield Energy Treated sample at 508 cm-1. 
Overall, FT-IR results suggested that there might be a 
significant impact of Biofield Energy Treatment on zinc 
chloride at the atomic level to decrease the force constant of 
Zn-Cl bonds. This result also supported with the PXRD data 
that Biofield Energy Treated sample might be the new 
polymorphic form of zinc chloride. 
 
Figure 2. FT-IR spectra of the control and Biofield Energy Treated zinc chloride. 
3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-visible spectra of both the control and Biofield 
Energy Treated zinc chloride are presented in Figure 3. The 
spectra of the control and treated sample showed the 
maximum absorbance (λmax) at 196.4 nm and 196.2 nm, 
respectively, along with the miner shift of absorbance 
maxima from 1.9084 (control sample) to 1.9259 (Biofield 
Energy Treated sample). The UV absorbance occurs due to 
the diverse type of energy transitions from the singlet to the 
singlet excited state such as 
σ → σ∗, n → π∗, and π → π∗. These type of electronic 
transitions occur when the difference in energy between the 
lowest unoccupied molecular orbital (LUMO) and the 
highest occupied molecular orbital (HOMO) is significantly 
higher than the activation energy of the compound [55]. The 
UV-vis spectroscopic analysis of zinc chloride displayed no 
change in the λmax of the Biofield Energy Treated sample 
compared to the control sample. Thus, the structural 
configuration or activation energy of the Biofield Energy 
Treated sample was not changed compared with the control 
sample. 
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Figure 3. UV-vis spectra of the control and Biofield Energy Treated zinc chloride. 
3.5. Differential Scanning Calorimetry (DSC) Analysis 
The DSC thermograms of the control and Biofield Energy 
Treated zinc chloride are presented in Figure 4. The 
melting/decomposition temperature and enthalpy of 
fusion/decomposition of the control and treated zinc chloride 
are presented in Table 3. The melting temperature was 
slightly decreased by 0.20% in the Biofield Energy Treated 
zinc chloride (310.88°C) compared with the control sample 
(311.49°C). The onset and the endset melting temperature 
were also decreased slightly by 0.17% and 0.20%, 
respectively in the Biofield Energy Treated sample compared 
with the control sample. The latent heat of fusion or enthalpy 
of fusion (∆Hfusion) of the control and Biofield Energy 
Treated zinc chloride was 309.83 J/g and 402.09 J/g, 
respectively. The ∆Hfusion of the Biofield Energy Treated 
sample was significantly increased by 29.78% compared with 
the control sample. Similarly, the decomposition temperature 
of the Biofield Energy Treated zinc chloride (385.41°C) was 
increased by 0.45% compared to the control sample 
(383.67°C). The onset and endset decomposition temperature 
were also increased slightly by 0.59% and 0.23%, 
respectively in the Biofield Energy Treated sample compared 
with the control sample. The enthalpy of decomposition 
(∆Hdecomposition) of the control and Biofield Energy Treated 
zinc chloride were 243.13 J/g and 626.37 J/g, respectively. 
The ∆Hdecomposition of the Biofield Energy Treated sample was 
significantly decreased by 61.18% compared with the control 
sample. Overall, the results indicated that the Biofield Energy 
Treated zinc chloride needs more energy in the form of latent 
heat to undergo the process of melting after Biofield Energy 
Treatment. It is anticipated that Biofield Energy Treatment 
might enhance the internal energy in zinc chloride that leads 
to increase of the decomposition temperature. Thus, the 
thermal stability of the Biofield Energy Treated sample might 
be more compared with the control sample. The enhanced 
thermal stability of a drug is an advantage in the maintenance 
of the product in long term storage condition throughout the 
shelf-life for any pharmaceutical formulations [56]. 
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Table 3. The latent heat of fusion (J/g), enthalpy of decomposition (J/g) and melting/decomposition temperature (°C) values of the control and Biofield Energy 
Treated zinc chloride. 
Endothermic peak Description Tonset (°C) Tpeak (°C) Tendset (°C)  ∆H (J/g) 
Endothermic peak 
Control sample 299.49 311.49 316.30 309.83 
Biofield Energy Treated sample 298.99 310.88 315.68 402.09 
% Change* -0.17 -0.20 -0.20 29.78 
Exothermic peak 
Control sample 380.43 383.67 385.00 626.37 
Biofield Energy Treated sample 382.67 385.41 385.90 243.13 
% Change* 0.59 0.45 0.23 -61.18 
Tonset:
 Onset melting/decomposition temperature, Tpeak: Peak melting/decomposition temperature, Tendset: Endset melting/decomposition temperature, ∆H: 
Enthalpy of fusion/decomposition, *denotes the percentage change of the Biofield Energy Treated sample with respect to the control sample. 
 
Figure 4. DSC thermograms of the control and Biofield Energy Treated zinc chloride. 
4. Conclusions 
The current experimental results revealed that The Trivedi 
Effect® - Consciousness Energy Healing Treatment had the 
significant effects on the physical, structural, thermal, and 
behavioral properties of zinc chloride. The PXRD data 
displayed the significant alteration of the crystallite size and 
relative intensities of the PXRD peaks in The Trivedi Effect® 
treated sample compared with the control sample. The 
average crystallite size of the treated sample was 
significantly increased by 16.43% compared with the control 
sample. The surface area of the treated sample was increased 
by 1.63% compared with the control sample. The FT-IR 
spectroscopic analysis revealed that Zn-Cl stretching in the 
control sample was 511 cm-1, whereas it was significantly 
shifted downward to 508 cm-1 in the treated sample. The DSC 
analysis exhibited that the melting temperature was not 
altered significantly, while decomposition temperature was 
increased by 0.45% in the treated sample compared to the 
control sample. The latent heat of fusion of the treated 
sample was significantly increased by 29.78% compared with 
the control sample. Similarly, the enthalpy of decomposition 
of the treated sample was significantly altered by 61.18% 
compared with the control sample. Thus, the Biofield Energy 
Treatment improve the thermal stability of the treated sample 
compared to the control sample. Briefly, The Trivedi Effect® 
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- Consciousness Energy Healing Treatment might introduce a 
new thermally stable polymorphic form of zinc chloride that 
could be more soluble and bioavailable compared with the 
untreated compound. Hence, Biofield Energy Treated zinc 
chloride would be very useful to design better nutraceutical 
and/or pharmaceutical formulations that might offer better 
therapeutic response against immunological disorders, 
inflammatory diseases, aging, stress, Wilson’s disease, 
cancer, viral diseases, parakeratosis, anorexia, hypogeusia, 
geophagia, dysosmia, hypogonadism, growth retardation, etc. 
Abbreviations 
DSC: Differential scanning calorimetry, FT-IR: Fourier 
transform infrared spectroscopy, FWHM: Full width half 
maximum, G: Crystallite size, HOMO: Highest energy occupied 
molecular orbital, LUMO: Lowest energy unoccupied molecular 
orbital, Tonset:
 Onset melting/decomposition temperature, Tpeak: 
Peak melting/decomposition temperature, Tendset: Endset 
melting/decomposition temperature, ∆H: Enthalpy of 
fusion/decomposition, UV-vis: Ultraviolet-visible spectroscopy, 
PSD: Particle size distribution, PXRD: Powder X-ray 
diffraction.  
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